Antibiotic prophylaxis in primary immune deficiency disorders

Area of Science:

• Immunology
• Infectious Diseases
• Pharmacology

Background:

• Long-term prophylactic antibiotics are common in primary immune deficiencies (PIDs).
• Their use has improved outcomes in various PIDs like chronic granulomatous disease and T-cell deficiencies.
• However, evidence is largely extrapolated from immunocompetent individuals and lacks controlled trials in PIDs, especially antibody deficiencies.

Purpose of the Study:

• To review the evidence for antibiotic prophylaxis in PIDs.
• To specifically highlight the role of antibiotic prophylaxis in primary antibody deficiency syndromes.
• To discuss the implications of long-term antibiotic use on resistant pathogens.

Main Methods:

• Literature review of existing studies and clinical practice surveys.
• Analysis of data from various primary immune deficiency populations.
• Discussion of antibiotic resistance associated with long-term use.

Main Results:

• Prophylactic antibiotics have transformed outcomes in several PIDs.
• Controlled trial data for primary antibody deficiency syndromes are scarce.
• Clinical practice varies significantly among immunologists due to a lack of guidelines.

Conclusions:

• Antibiotic prophylaxis is crucial in managing PIDs, but its application in antibody deficiencies requires more robust evidence.
• The current practice is often based on extrapolation, highlighting a need for standardized protocols.
• Future multicenter prospective trials are essential to investigate prophylactic antibiotic use in antibody deficiency syndromes, given limited alternative treatments.